A detailed history of Qtron Investments LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Qtron Investments LLC holds 14,240 shares of RPRX stock, worth $557,638. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,240
Previous 11,302 26.0%
Holding current value
$557,638
Previous $407,000 23.34%
% of portfolio
0.06%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$34.9 - $37.91 $102,536 - $111,379
2,938 Added 26.0%
14,240 $502,000
Q2 2025

Aug 13, 2025

BUY
$30.85 - $36.14 $348,666 - $408,454
11,302 New
11,302 $407,000
Q3 2022

Nov 10, 2022

BUY
$39.88 - $44.65 $394,612 - $441,811
9,895 New
9,895 $398,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $17.1B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.